Grass allergy . Circassia recently initiated phase II scientific tests of its grass allergy T-cell vaccine. Outcomes from the scholarly research are anticipated in 2011. 4. House dust mite allergy. Circassia’s therapy for house dirt mite allergy began stage II testing in early 2010. The original study is near completion. ‘These recent clinical advancements demonstrate Circassia’s commitment to bringing its exclusive T-cell allergy vaccines to advertise as rapidly as feasible,’ stated Steve Harris, Circassia’s CEO. ‘Because the founding of Circassia just four years back, our ToleroMune technology provides successfully completed multiple stage II studies, and we have four therapies in mid-stage development now, targeting probably the most common allergic reactions in the global globe.Utilizing a detailed statistical evaluation to evaluate tea drinking with disease prices, the scientists could actually conclude the result of dark tea drinking on wellness indicators at a people level. The group conducting the evaluation found black tea usage had a direct effect on the price of diabetes instances, but didn’t correspond to the other wellness parameters studied. Statistical indicators pointed to a solid linear association between low prices of diabetes in countries where intake of black tea can be high. The authors concluded These unique study results are in keeping with prior biological, physiological, and ecological research carried out on the potential of [dark tea] on diabetes and obesity . Plus they provide valuable additional scientific details at the global level.